Diclofenac

Generic Name
Diclofenac
Brand Names
Aleve Arthritis Pain, Arthrotec, Cambia, Cataflam, Flector, Licart, Lofena, Pennsaid, Previdolrx Analgesic Pak, Salonpas Pain Relieving Patch, Solaraze, Voltaren, Voltaren Emulgel, Xrylix, Zipsor, Zorvolex
Drug Type
Small Molecule
Chemical Formula
C14H11Cl2NO2
CAS Number
15307-86-5
Unique Ingredient Identifier
144O8QL0L1
Background

Diclofenac is a phenylacetic acid derivative and non-steroidal anti-inflammatory drug (NSAID). NSAIDs inhibit cyclooxygenase (COX)-1 and-2 which are the enzyme responsible for producing prostaglandins (PGs). PGs contribute to inflammation and pain signalling. Diclofenac, like other NSAIDs, is often used as first line therapy for acute and chronic pain and in...

Indication

Diclofenac is indicated for use in the treatment of pain and inflammation from varying sources including inflammatory conditions such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, as well as injury-related inflammation due to surgery and physical trauma. It is often used in combination with misoprostol as a gastro-protective agent in p...

Associated Conditions
Actinic Keratosis (AK), Acute Arthritis, Acute Gouty Arthritis, Acute Migraine, Acute Musculoskeletal Pain, Ankylosing Spondylitis (AS), Common Cold, Fever, Gout, Inflammation, Inflammatory Disease of the Oral Cavity, Inflammatory Disease of the throat, Inflammatory Reaction of the Nerve, Joint Pain, Juvenile Idiopathic Arthritis (JIA), Menstrual Distress (Dysmenorrhea), Muscle Inflammation, Myalgia, Neuropathic Pain, Ocular Inflammation, Osteoarthritis (OA), Osteoarthritis of the Knee, Pain, Pain caused by Rheumatism, Pericarditis, Photophobia, Postoperative Inflammatory Response, Postoperative pain, Primary Dysmenorrhoea, Radicular Pain, Rheumatism, Rheumatoid Arthritis, Seasonal Allergic Conjunctivitis, Spinal pain, Tendon pain, Vertebral column pain, Acute Musculoskeletal injury, Acute, moderate, severe Pain, Inflammatory, Localized soft tissue rheumatism, Mild to moderate joint pain, Mild to moderate pain, Minor pain, Perioperative miosis
Associated Therapies
-

Diclofenac Administered Before Skull Operations Reduces the Severity of Headache After the Intervention

First Posted Date
2013-07-25
Last Posted Date
2013-07-25
Lead Sponsor
University of Debrecen
Target Recruit Count
200
Registration Number
NCT01907984
Locations
🇭🇺

University of Debrecen Medical and Health Science Center Department of Anesthesiology and Intensive Care, Debrecen, Hajdú-Bihar, Hungary

Pharmacokinetic Drug Interaction Between YH4808 and Diclofenac

Phase 1
Completed
Conditions
Interventions
First Posted Date
2013-06-12
Last Posted Date
2014-01-01
Lead Sponsor
Yuhan Corporation
Target Recruit Count
49
Registration Number
NCT01876615
Locations
🇰🇷

Chungnam National University Hospital, Daejeon, Korea, Republic of

NSAID Treatment in Knee Osteoarthritis

First Posted Date
2013-05-23
Last Posted Date
2013-05-23
Lead Sponsor
University of Catanzaro
Target Recruit Count
90
Registration Number
NCT01860833
Locations
🇮🇹

Department of Orthopedic and Trauma Surgery, Catanzaro, Italy

Intrathecal Levobupivacaine With Opioids for Caesarean Section

First Posted Date
2013-05-21
Last Posted Date
2013-05-21
Lead Sponsor
Baskent University
Target Recruit Count
93
Registration Number
NCT01858090
Locations
🇹🇷

Baskent University School of Medicine Adana Teaching and Research Hospital, Adana, Turkey

Diclofenac Suppository to Control Pain During Flexible Cystoscopy

Phase 2
Completed
Conditions
Interventions
First Posted Date
2013-03-18
Last Posted Date
2013-12-17
Lead Sponsor
Aga Khan University
Target Recruit Count
60
Registration Number
NCT01812928
Locations
🇵🇰

Aga Khan University Hospital, Karachi, Sindh, Pakistan

Efficacy of Diclofenac on Pain During Endometrial Sampling

First Posted Date
2013-01-07
Last Posted Date
2013-01-07
Lead Sponsor
Mahidol University
Target Recruit Count
90
Registration Number
NCT01762306
Locations
🇹🇭

Faculty of Medicine Siriraj Hospital Mahidol University, Bangkok, Thailand

Intramuscular Diclofenac in the Prevention of Post-ERCP Pancreatitis

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2012-10-30
Last Posted Date
2021-05-04
Lead Sponsor
Yonsei University
Target Recruit Count
343
Registration Number
NCT01717599
Locations
🇰🇷

Division of Gastroenterology, Department of Internal Medicine, Yonsei Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea, Republic of

Injectable Diclofenac for the Prevention of Post-operative Dental Pain

Phase 2
Completed
Conditions
Interventions
First Posted Date
2012-10-15
Last Posted Date
2014-09-05
Lead Sponsor
IBSA Institut Biochimique SA
Target Recruit Count
75
Registration Number
NCT01706588
Locations
🇬🇧

The School of Dentistry University of Birmingham, Birmingham, United Kingdom

Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid Tumors

First Posted Date
2012-05-11
Last Posted Date
2020-12-21
Lead Sponsor
Novartis Pharmaceuticals
Target Recruit Count
39
Registration Number
NCT01596647
Locations
🇺🇸

Comprehensive Cancer Centers, Las Vegas, Nevada, United States

🇺🇸

University of Kansas Cancer Center Medical Center, Kansas City, Kansas, United States

🇺🇸

Henry Ford Hospital Henry Ford, Detroit, Michigan, United States

and more 2 locations

Diclofenac for Submassive PE

Phase 2
Terminated
Conditions
Interventions
First Posted Date
2012-05-02
Last Posted Date
2017-09-06
Lead Sponsor
Ministry of Health, Spain
Target Recruit Count
34
Registration Number
NCT01590342
Locations
🇪🇸

Ramon y Cajal Hospital, IRYCIS, Madrid, Spain

© Copyright 2024. All Rights Reserved by MedPath